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ABSTRACT - Word Count: 239 
 
Background: Gait impairment in people with Multiple Sclerosis results from neurological impairment, 
muscle weakness and reduced range of motion. Restrictions in passive ankle range of motion can result 
in abnormal heel-to-toe progression (weight transfer) and inefficient gait patterns in people with Multiple 
Sclerosis. The purpose of this study was to determine the associations between gait impairment, heel-to-
toe progression and ankle range of motion in people with Multiple Sclerosis.  
 
Methods: Twelve participants with Multiple Sclerosis and twelve healthy age-matched participants were 
assessed. Spatiotemporal parameters of gait and individual footprint data were used to investigate group 
differences. A pressure sensitive walkway was used to divide each footprint into three phases (contact, 
mid-stance, propulsive) and calculate the heel-to-toe progression during the stance phase of gait. 
 
Findings: Compared to healthy controls, people with Multiple Sclerosis spent relatively less time in 
contact phase (7.8% vs 25.1%) and more time in the mid stance phase of gait (57.3% vs 33.7%). Inter-
limb differences were observed in people with Multiple Sclerosis between the affected and non-affected 
sides for contact (7.8% vs 15.3%) and mid stance (57.3% and 47.1%) phases. Differences in heel-to-toe 
progression remained significant after adjusting for walking speed and were correlated with walking 
distance and ankle range of motion. 
 
Interpretation: Impaired heel-to-toe progression was related to poor ankle range of motion in people with 
Multiple Sclerosis.  Heel-to-toe progression provided a sensitive measure for assessing gait impairments 
that were not detectable using standard spatiotemporal gait parameters.  
 
Keywords: Heel – Toe sequence, Footprint, Ankle Rocker, Electronic walkway, Gait Impairment  
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1. Introduction 
Multiple Sclerosis (MS) is a chronic neurodegenerative disease that effects over 23,000 people in 
Australia (Australian Bureau of Statistics, 2012). People with Multiple Sclerosis (PwMS) identify 
restrictions in gait as their most common and problematic concern (Heesen et al., 2008; Hobart, Riazi, 
Lamping, Fitzpatrick, & Thompson, 2003). Similar to patients with cerebral palsy (CP) and stroke 
(Schmid, Schweizer, Romkes, Lorenzetti, & Brunner, 2013), gait impairments in PwMS may result from 
neurological impairments, muscle weaknesses and reduced ankle range of motion (RoM), often referred 
to as “joint contractures” (Hoang, Gandevia, & Herbert, 2013). Ankle joint contractures are common in 
PwMS and are associated with impaired walking ability. 
 
Healthy gait is defined by regular heel-to-toe progression (weight transfer) that facilitates efficient 
locomotion. Heel-to-toe progression refers to foot movement that begins with heel contact and ends with 
toe off. Effective heel-to-toe progression is essential in preserving momentum during the stance phase of 
gait and is influenced by functional ankle and foot rockers (Perry, Burnfield, & Cabico, 1992). Ankle 
rocking during the stance phase of gait acts as a pivot point to allow for tibial progression. Adequate 
passive ankle dorsiflexion is needed to allow for forward progression of the tibia over the foot (Perry et al., 
1992). Normal heel-to-toe progression is compromised by ankle contractures (Maurer et al., 1995) and 
can result in inefficient compensation strategies (such as knee hyperextension) often evident in people 
with neurological conditions (Schmid et al., 2013). 
 
Heel-to-toe progression can be measured using force platforms and 3D motion capture systems. 
However, such analysis may be time consuming and limited to a few steps making it less practical for 
clinical settings (van den Noort, Ferrari, Cutti, Becher, & Harlaar, 2013). In lieu, gait impairments are often 
assessed using observational rating scales, which may lack sensitivity to detect subtle changes in gait 
patterns (Spain et al., 2012). Portable electronic walkways overcome these limitations and have been 
used to quantify spatiotemporal gait patterns (e.g. step length, step time and stepping variability) in PwMS 
(Sosnoff, Weikert, Dlugonski, Smith, & Motl, 2011) and for footprint analysis in healthy people (Titianova, 
Mateev, & Tarkka, 2004).  
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The purpose of this study was to determine the associations between gait impairment, heel-to-toe 
progression and ankle RoM in PwMS. A novel method of footprint analysis was used to provide 
information about how abnormal heel-to-toe progression may affect mobility in people with and without 
MS during a six-minute walk test (6MWT).  Accurate assessment of heel-to-toe progression in the clinical 
setting could help inform rehabilitation aimed at improving functional mobility in a variety of neurologically 
gait impaired populations. 
 
2. Methods 
2.1 Participants 
Twelve healthy participants (four males and eight females) and twelve participants with MS (three males 
and nine females) took part in the study. Healthy participants were matched where possible for age, sex, 
height and body mass (Table 1). Inclusion criteria for eligible participants in the MS group included; i) a 
confirmed diagnosis of MS by a neurologist; ii) An Expanded Disability Status Scale (EDSS) of  6 and 
able to walk independently; iii) no relapses within the past 12 weeks; iv) free from any other disease, 
injury or illness preventing them from participating in a 6MWT. Participants were excluded from the study 
if they required the use of a foot-ankle orthosis as such devices interferer with normal heel-toe 
sequencing. All healthy controls were free from disease, injury or illness that affected gait. The study was 
approved by the Human Studies Ethics Committee at the University of New South Wales. Informed 
consent was obtained from all participants prior to participation. 
 
2.2 Ankle Range of Motion Assessment 
Adequate RoM is essential for normal, efficient locomotion. As ankle RoM can influence heel-to-toe 
progression (Maurer et al., 1995), passive RoM was measured on the more affected side in PwMS to 
assess the overall RoM available at the ankle joint. Joint contractures are often assessed in the clinic 
using passive ankle RoM (Diong et al., 2012; Kwah et al., 2012). Briefly, 100N of pulling force was 
applied to the heads of the metatarsals, parallel to the shank and the ankle angle was measured using an 
inclinometer (Rippstein - Plurimeter). 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IPT
 
5 
 
 
2.3 Gait assessments 
Participants completed a 6MWT wearing comfortable footwear at a self-selected fast walking speed on a 
twenty-metre walking pathway. A standard protocol was used. Participants were instructed “to walk as far 
as possible for 6 minutes”. Participants were reminded that they would be walking for 6 minutes and could 
stop and rest if needed. Participants were given standardised encouragement after each minute. A six-
metre long GAITRite
TM
 mat was positioned four metres from the start of the walking pathway to ensure 
normal gait patterns had resumed after each turn. Spatiotemporal measures were collected along with 
the footprint data of each step and exported for subsequent analysis. Multiple passes over the 
measurement area were combined for each participant.  
 
2.4 Heel-to-toe progression 
Only complete foot prints were used in the analyses. Each footprint was divided into three equal areas 
that defined the heel, mid-foot and forefoot sensors (Figure 1). Sensor activation and deactivation data for 
each were then used to calculate the Contact, Mid Stance and Propulsive phases of gait (Figure 1).   
Contact phase began with heel strike and terminated with forefoot loading and contact duration was 
calculated by subtracting the ‘heel on’ time from the ‘toe on’ time. Mid stance phase began with forefoot 
loading and terminated at heel lift and duration was calculated by subtracting ‘toe on’ time from ‘heel off’ 
time. The propulsive phase began with heel lift and terminated at toe off and was calculated by 
subtracting ‘heel off’ time from ‘toe off’ time. The phase durations were then normalised by dividing by 
total foot contact time and gait phases were reported as a percentage for the subsequent statistical 
analysis. 
 
2.4 Statistical Analysis 
Analyses were performed with SPSS statistical package (version 23). Analysis of variance (ANOVA) was 
used to assess group differences in heel-to-toe progression and mobility measures for people with and 
without MS and between affected and non-affected sides for PwMS. Post-hoc t-tests and effect sizes, 
Cohen’s d  (Cohen, 1992) were calculated to assess between group differences. Because a large effect 
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for gait velocity was observed (d=-1.82, Table 1), analysis of covariance (ANCOVA) was further 
undertaken to determine if the group differences remained significant after adjusting for walking speed. 
Pearson’s correlations were used to investigate any associations between heel-to-toe progression and 
participant demographics. Significance was set at p < 0.05 for all comparisons. A post-hoc power analysis 
(two tailed, p =.05) was conducted with the program G*Power (Faul, Erdfelder, Lang, & Buchner, 2007) to 
ascertain if our study was sufficiently powered to detect the group differences in 6MWT performances. 
 
3. Results 
PwMS had similar demographics to the healthy controls (Table 1), but had significantly reduced passive 
ankle RoM (87.9º vs 96.6º) and shorter six-minute walk distances (330m vs 506m). The average EDSS of 
PwMS was 4.1 (SD=1.2) representing a moderate level of disability. 
 
With respect to the spatiotemporal assessments, PwMS walked significantly slower (1.02ms
-1
 vs 1.57ms
-
1
, d=-1.82) with lower cadence (98.8steps/min vs 121.2 steps/min, d=-1.49), shorter step lengths (61.5cm 
vs 77.5cm, d=-1.71) and longer stance times (0.08s vs 0.61s, d=1.43) than the healthy controls. However, 
the differences in cadence, step length and stance time did not remain significant after adjusting for using 
ANCOVA (Table 2).  
 
With respect to quantifying heel-to-toe progression, PwMS spent a lower proportion of stance time in the 
contact phase (7.8% vs 25.1%, d=-3.21) and a greater proportion of time in the mid stance phase (57.3% 
vs 33.7%, d=2.61) than the heathy controls. The large effects (Cohen, 1992) of MS on heel-to-toe 
progression remained significant after adjusting for walking speed using ANCOVA (Table 2). Furthermore, 
in PwMS, significant differences between the affected and non-affected side were only observed in the 
assessment of heel-to-toe progression (Figure 2 & 3). Compared to the non-affected side, on the effected 
side PwMS spent a lower proportion of stance time in contact phase (7.8% vs 15.3%, d=-1.33) and a 
greater proportion in mid stance phase (57.3% vs 47.1%, d=0.91). 
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The post hoc power analysis was based on the observed differences in 6MWT distances (176m, Table 1), 
pooled standard deviation (99m) and the mean performance of the healthy controls (506m). The effect of 
MS on walking distance (d=-1.78) was large (Cohen, 1992). The power to detect an effect of this size in 
the present study comprising PwMS (n=12) and healthy controls (n=12) was high (>98%). This indicates 
the study was sufficiently powered to investigate gait differences between people with and without MS.  
 
With respect to the participant demographics and background clinical assessments (Table 1) poor heel-
to-toe progression was associated with reduced ankle passive RoM and shorter 6MWTs but not with 
differences in sex, age, height, weight or BMI. A reduction in the contact phase of gait was significantly 
(p≤0.05) correlated with decreased 6MWT distances (r
2
= 0.42) and decreased passive range of ankle 
motion (r
2
= 0.18). An increase in the mid-stance phase of gait was significantly (p≤0.05) correlated with 
decreased 6MWT distances (r
2
= 0.64) and decreased range of ankle motion (r
2
= 0.17). 
 
4. Discussion 
People with Multiple Sclerosis develop restrictions in ankle RoM that results in abnormal gait patterns. 
This study aimed to identify the associations between gait impairment, heel-to-toe progression and ankle 
RoM in PwMS. Results demonstrated that heel-to-toe progression is impaired in PwMS. Compared to 
healthy controls, PwMS spent relatively less time in the contact phase and more time in the mid-stance 
phase of gait. The large effect sizes observed for both the contact phase (d=-3.21) and the mid-stance 
phase of gait (d=2.61) indicates the potential clinical utility of assessing heel-to-toe progression 
objectively. In our study, the impaired heel-to-toe progression in PwMS was correlated with reductions in 
both passive ankle RoM and 6MWT distance (r
2
= 0.17 to 0.64), highlighting a plausible functional 
pathway between clinically assessed contracture (reduced passive ankle RoM), inefficient gait patterns 
and reduced mobility in PwMS. 
 
Consistent with previous research, PwMS completed a significantly shorter 6MWT distance, walked 
slower with lower cadences, took shorter steps and spent more time in the stance phase of gait (Givon, 
Zeilig, & Achiron, 2009; Sosnoff et al., 2011). Asymmetric spastic para-paresis is a common gait pattern 
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in PwMS (Stevens, Goodman, Rough, & Kraft, 2013) and side to side variability is often reported 
(Benedetti et al., 1999). However, in the current study, significant differences between the affected and 
non-affected sides were only observed in measures of heel-to-toe progression; percentage contact time 
and percentage mid stance, but not in measures of step length or stance time as previously suggested to 
be common in neurological populations such as MS (Benedetti et al., 1999) and Stroke (Patterson, Gage, 
Brooks, Black, & McIlroy, 2010).  
 
The objective assessment of heel-to-toe progression had two main advantages over the traditional 
spatiotemporal parameters of cadence, step length and stance time. Firstly, differences were detected 
between the affected and non-affected limbs and secondly, differences remained significant after 
adjusting for walking speed. Together this suggests that the quantification of heel-to-toe progression may 
reveal subtle gait abnormalities related to gait symmetry that assessment of step lengths and stance 
times may not detect.  
 
It has previously been reported that ankle joint contractures can influence gait patterns (Hoang et al., 
2013), and that abnormal heel-to-toe progression can result from reduced RoM at the ankle joint (Maurer 
et al., 1995). Consistent with these findings, we found PwMS had significantly reduced passive RoM at 
the ankle when compared to healthy controls. Reduced passive ankle RoM was moderately correlated 
with both the reduction in the contact phase of gait (r
2
= 0.18) and the increase in the mid-stance phase of 
gait (r
2
= 0.17). Furthermore, we found decreased 6MWT performances were strongly correlated with both 
the reduction in the contact phase of gait (r
2
= 0.42) and the increase in the mid-stance phase of gait (r
2
= 
0.64).  Impaired heel-to-toe progression potentially provides a functional link between ankle joint 
contractures and mobility limitations in PwMS and therefore may offer a new target for rehabilitation. 
 
Effective heel-to-toe progression is essential for maintaining momentum and efficiency during gait (Perry 
et al., 1992). Contact support period in our analysis was terminated with forefoot loading. The rapidity of 
this loading or plantarflexion at initial contact (IC) is regulated by the pretibial muscles including the tibialis 
anterior, extensor hallucis longus and extensor digitorium longus. Our results also demonstrated a 
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significant difference between affected (7.8%) and non-affected (15.3%) limbs throughout the contact 
phase of stance which was potentially caused by a combination of weakness associated with the pretibial 
muscles and restrictions in ankle RoM commonly observed in PwMS (Hoang et al., 2013; Perry et al., 
1992).  
 
The reduction of time spent in the contact phase was inversely associated with greater time spent in the 
mid-stance phase. The significant increases detected between the affected (57.3%) and non-affected 
(47.1%) limbs during the mid-stance phase of gait can alter forward progression and result in 
compensation strategies such as knee hyperextension to aid with locomotion (Schmid et al., 2013). The 
propulsive phase of gait demonstrated no significant differences between PwMS and healthy controls 
suggesting PwMS may employ a variety of compensatory gait strategies such as vaulting which could 
influence the amount of time spent in this period leading up to toe off. 
 
We acknowledge certain study limitations. First, our cohort included participants with an average EDSS 
score of 4.1 (SD=1.2) representing a moderate level of disability within the MS population. Therefore, 
care must be taken with generalising our findings to MS populations with higher EDSS scores because 
the severity of the disease can influence gait patterns and may affect heel-to-toe progression. Second, 
our small sample size (n=24) was relatively small. However, the post-hoc power analysis revealed our 
study was sufficiently powered to investigate group differences because the effects of MS on walking 
ability were large. Further investigation is now required to better understand the mechanism causing the 
inter-limb differences in heel-to-toe progression. Specifically, it was a limitation that only passive ankle 
RoM was assessed and future research should also investigate the relationship between active ankle 
RoM during walking and heel-to-toe progression. Future research could also investigate the sensitivity of 
heel-to-toe progression to changes in gait associated with other neurological conditions such as Stroke 
and Parkinson’s disease and determine if targeted interventions can modify heel-to-toe progression and 
therefore improve mobility. 
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5. Conclusions 
In summary, the study findings demonstrate that objective assessment of heel-to-toe progression during a 
six-minute walk test identified functionally and clinically important differences in the gait of people with 
multiple sclerosis and potentially provides a new target for improving mobility in PwMS.  
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Table 1 
Participant characteristics, passive ankle range of motion and six-minute walking distance for people with 
MS and health controls 
 
People with MS Healthy Controls ANOVA 
 
Mean SD Mean SD p-value 
Sex (male=1) 1.75 0.45 1.67 0.49 0.67 
Age [years] 52.0 9.1 55.8 12.23 0.40 
Height [m] 1.69 0.06 1.65 0.09 0.21 
Mass [kg] 71.5 17.9 72.3 9.91 0.89 
BMI [kg/m2] 25.1 5.7 26.8 3.34 0.39 
Passive Ankle RoM [º] 87.9 7.8 96.6 5.92 0.006 
6MWT [m] 330 112 506 82.64 <0.001 
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Table 2  
Heel-to-toe progression, spatiotemporal and mobility measures assessed during the six-minute walk test for people with MS and healthy controls. 
 
 
ANCOVA – Analysis of covariance adjusting for walking speed.  
*% Contact - Time between heel loading and forefoot loading (Toe On – Heel On / Total Time) 
**% Mid Stance - Time between forefoot loading and heel lift (Heel Off – Toe On / Total Time) 
***% Propulsion - Time between heel lift and toe off (Toe Off – Heel Off / Total Time) 
 
 
 
MS Healthy Control ANOVA ANCOVA 
Effect sizes Cohen’s d 
Mean SD Mean SD p-value p-value 
Mobility measures 
 
Velocity [m/s] 1.02 0.35 1.57 0.24 < 0.001 N/A -1.82 
Cadence [steps/min] 98.8 20.1 121.2 6.8 0.001 0.83 -1.49 
 
 
1. MS 
Affected 
2. MS Non 
Affected 
3. Healthy 
Controls 
ANOVA ANCOVA Post-hoc t-tests & Effect sizes Cohen’s d 
Mean SD Mean SD Mean SD p-value p-value 1 vs 2 d 1 vs 3 d 2 vs 3 d 
Heel-to-Toe progression 
% Contact* 7.8 5.1 15.3 6.1 25.1 5.8 <0.001 <0.001 0.004 -1.33 <0.001 -3.21 0.001 -1.63 
% Mid Stance** 57.3 12.6 47.1 9.4 33.7 8.8 <0.001 0.005 0.03 0.91 <0.001 2.16 0.002 1.47 
% Propulsion*** 34.9 10.8 37.6 7.6 41.2 6.6 0.21 0.69 0.48 -0.29 0.10 -0.70 0.23 -0.50 
Spatiotemporal measures 
Step Length [cm] 61.5 9.5 60.5 11.3 77.5 9.2 <0.001 0.78 0.83 0.09 <0.001 -1.71 0.001 -1.64 
Toe Out [º] 10.3 6.4 6.6 10.0 4.4 5.4 0.17 0.42 0.29 0.45 0.02 0.99 0.52 0.27 
Stance Time [s] 0.80 0.17 0.88 0.23 0.61 0.05 0.002 0.11 0.36 -0.38 0.002 1.43 0.001 1.56 
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Figure 1  
GAITRite
TM 
Footprint Analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The contact phase begins with heel ON and is terminated with forefoot ON. The mid stance phase begins with 
forefoot ON and is terminated at heel OFF. The propulsive phase begins with heel OFF and is terminated at forefoot 
OFF. 
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Figure 2  
Stance phase percentages 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Significant difference in % Contact and % Mid stance between affected, non-affected and healthy groups. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*
*
*
*
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Figure 3  
Heel-to-toe progression during stance 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
*Significant difference in Contact % between affected, non-affected and healthy groups.   
**Significant difference in Mid Stance % between affected, non-affected and healthy groups.   
   
 
  
*
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REVISED HIGHLIGHTS 
 
 Heel-to-toe progression was measured in people with and without multiple sclerosis. 
 In people with multiple sclerosis, heel-to-toe progression was severely 
compromised. 
 Impaired heel-to-toe progression was related to poor ankle range of motion. 
 The new test revealed functionally and clinically important inter-limb differences. 
 Heel-to-toe progression is a sensitive measure to detect gait abnormalities. 
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